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Fear of recurrence
RobeRto C. HeRos, M.D.
Department of Neurosurgery, University of Miami, Florida
This issue of the Journal of Neurosurgery contains 
an interesting article by Covey and colleagues on the im-
portant issue of the fear of recurrent subarachnoid hemor-
rhage (SAH) in patients and their significant other (SO), 
who was usually the spouse but could be another family 
member or close friend most intimately identified with 
the patient.1 Essentially, the authors attempted to quantify 
by neuropsychological testing the magnitude of that fear 
and its effect on the general well-being of the patient and 
his/her SO. Not surprisingly, they found that the fear fac-
tor was of substantial magnitude and that it significantly 
impacted the quality of life of the patient. Surprisingly, 
however, they found that this fear of recurrence was ac-
tually greater in the SO than in the patient and that fear 
on the part of the SO had a very significant effect on the 
quality of life of the patient, presumably by excessive 
“nurturing” and imposition on the patient by his/her SO 
of restrictions on things such as return to work, physical 
activity, driving, sexual intercourse, and so on. Interest-
ingly, the authors found that the fear of recurrent SAH in 
these patients and their SO was greater than the fear of 
the patient developing Parkinson disease, lung cancer, or 
a heart attack. Perhaps this can be explained by the fact 
that the fear of a recurrence of something that the patient 
has already experienced far outweighs the impact of the 
fear of other equally serious but hypothetical problems 
that the patient has not experienced personally.
Like most studies, this one has some weaknesses that 
the authors have done a good job in discussing. First of all, 
it should be noted that none of the 3 authors is a neuro-
surgeon, and therefore the study has a strict psychological 
perspective. Additionally, the number of patients (69) is 
small and this is a highly selected population of patients 
who were obviously in good neurological condition at the 
time that the psychological evaluation was applied (ap-
proximately 13 months after the ictus) and, as expected, 
the great majority of them (71%) were World Federation 
of Neurosurgical Societies Grade I at the time of their 
SAH. An additional bias is that the study was conducted 
through permission by the patient, who then allowed his/
her SO to be contacted for the test; this may have selected 
a particular group of patients in whom the issue of fear of 
recurrence by the SO and its impact on the patient may 
have been more important.
Needless to say, I cannot comment with any degree of 
expertise on the validity of the neuropsychological tests 
administered or the statistical interpretation of the results. 
Therefore, I will confine my comments to the role of the 
neurosurgeon in promoting or mitigating the fear of re-
current SAH in our patients and their SOs. My comments 
will by necessity be highly subjective and derived from 
personal experience much more than from scientific data, 
which is very scarce on this topic. Additionally, I do not 
think that it is necessary to discuss the patients who have 
had an aneurysmal SAH and in whom the aneurysm has 
either not been treated or has been incompletely coiled 
or incompletely clipped. It is obvious that these patients 
need to be followed up very carefully in a routine man-
ner, and there are fairly good guidelines about this. Like-
wise, enough data have now been gathered to know that 
there is a significant rate of recurrence of aneurysms that 
have been initially completely coiled, and again there are 
good guidelines on how these patients should be followed 
up. The issue I want to discuss is the one with which I 
have had the most experience; the patient who has had an 
SAH from a single aneurysm that has been satisfactorily 
clipped at surgery, with complete occlusion being con-
firmed either by intraoperative observation or, preferably, 
by angiography done during surgery or postoperatively.
I will begin my discussion by briefly supporting the 
widely held notion that the risk of a recurrent SAH from 
a satisfactorily clipped aneurysm or of developing a de 
novo aneurysm that could potentially result in an SAH is 
very, very small. David et al.2 reported on a consecutive 
group of 102 patients with 167 aneurysms in whom a late 
angiogram was obtained at a mean of 4.4 years after clip-
ping of a ruptured aneurysm by an expert neurosurgeon. 
Only 1 of these patients had a recurrent SAH during the 
follow-up period, which resulted in a calculated yearly 
rate of rebleeding of 0.26%. There were only 2 aneurysms 
that recurred from the group of patients who had complete 
clipping of the aneurysm confirmed by intraoperative or 
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early postoperative angiography. There were 8 de novo 
aneurysms found on late angiographic studies, but 7 of 
these developed in patients who had multiple aneurysms, 
and there was only 1 de novo aneurysm in patients who 
had a single aneurysm satisfactorily clipped. In the In-
ternational Subarachnoid Aneurysm Trial, over a 4-year 
period of follow-up there were only 2 rehemorrhages in 
the group of 1055 patients who had their ruptured aneu-
rysm clipped.3 
Wermer et al.5 reported 18 recurrent SAHs out of a 
group of 752 patients with a total of 6016 years of fol-
low-up (mean follow-up 8 years). Of these 18 recurrent 
rehemorrhages, only 4 were found to be from the aneu-
rysm that had bled previously and was clipped, which 
results in a 0.53% incidence of recurrent SAH from the 
clipped aneurysm. In this series, however, complete clip-
ping of the aneurysm was not confirmed by intraopera-
tive or immediate postoperative angiography. This study 
also confirmed that the presence of multiple aneurysms 
was a very significant risk factor for recurrent SAH. Fi-
nally, Tsutsumi and colleagues4 found a cumulative risk 
of recurrent hemorrhage of 2.2% over a 10-year follow-up 
period in 220 patients with a clipped aneurysm, and only 
2 patients (0.9%) had regrowth of the originally clipped 
aneurysm at follow-up angiography.
Accepting the fact that the risk of recurrent SAH 
from a satisfactorily clipped aneurysm or of developing 
a new aneurysm is extremely small, how should the treat-
ing neurosurgeon counsel the patient and his/her SO after 
recovery from an aneurysmal SAH and satisfactory clip-
ping of a single aneurysm that was responsible for the 
SAH? At one extreme would be to advise the patient that 
“You are cured and you don’t have to worry any more 
about an aneurysm. You don’t need to see me on a rou-
tine basis unless there is a problem, but I don’t expect 
any problems.” Or at the other extreme, “You know even 
though this aneurysm was taken care of for now, it could 
recur in the future and you could have another SAH or 
you may develop a new aneurysm, so we need to follow 
you very closely and repeat the angiogram periodically to 
make sure that this aneurysm remains occluded and that 
you don’t develop any other aneurysms, which is some-
thing that is more likely to happen after you already have 
had a ruptured aneurysm.” 
I don’t think there should be any question about the 
fact that speaking to the patient and the SO in the former 
manner could have a significant effect in alleviating a fear 
of recurrence, whereas that fear could be very significant-
ly exacerbated by the second statement. Perhaps most of 
us would agree that the best way to advise the patient falls 
in between these two extreme approaches. As in every-
thing else we do, it is hard not to have to contend, unpleas-
ant as this is to all of us, with medicolegal implications. 
Clearly, the physician making the second statement, par-
ticularly if it is well documented in the patient’s record, 
may feel well “protected” from the medicolegal point of 
view if the patient does indeed suffer a recurrent SAH 
or develops a new aneurysm in the future. The physician 
making the first statement about the patient being cured 
and not having to worry any more about another SAH or 
aneurysm may feel more vulnerable from this point of 
view. Therefore, each one of us would have to make an 
ethical but practical decision about the relative weight of 
the extremely small probability of being sued because of 
a recurrence in the future and the possible impact of our 
advice to the patient and his/her SO on the patient’s future 
mental health and well-being.
Before continuing, I would like to digress with a per-
sonal experience that stimulated my interest in this issue 
early in my career. Having moved to a new institution 
where I was to specialize in cerebrovascular surgery, I 
was instructed that one of my duties was to attend the 
monthly “aneurysm clinic.” I went to the first of these 
clinics very excited, thinking that I would see new pa-
tients with unruptured aneurysms who were coming for 
evaluation and possible treatment. Not so. Every patient 
I saw had had his/her aneurysm already treated, and in 
most cases the treatment had been complete and satisfac-
tory, and had taken place years (sometimes several years) 
before the clinic visit. It became evident to me during that 
initial clinic that almost all of these patients now had an 
“aneurysm disease” and that they believed that they had 
a chronic illness, and many of them dreaded this checkup 
visit for fear that “the aneurysm had come back.” Further-
more, I found it difficult to “cure” some of these patients 
from their aneurysm disease by telling them that they had 
an extremely small chance of a recurrent SAH or a new 
aneurysm and that they did not need any further follow-
up unless they had a problem. It seemed to me that after 
they had the “disease” for a few years, they couldn’t trust 
me to offer them an instantaneous “cure.” Needless to 
say, in a few months I was able to close down this “aneu-
rysm clinic” and started to counsel patients individually 
after clipping the aneurysm, advising follow-up to some 
and not to others depending on many factors such as age, 
multiplicity of aneurysms, known residual neck, presence 
or absence of family history, psychological makeup of the 
patient, and so on.  
As in so many “gray areas” in our specialty, I do not 
believe that we can or should develop guidelines on how 
each neurosurgeon should approach his or her patient af-
ter satisfactory treatment of a ruptured aneurysm. The 
best advice, as in most instances, is to be a complete phy-
sician and consider not just the scientific facts (extremely 
small chance of recurrence) but also the softer issue of 
psychological impact on the patient and his/her family, 
and to reach an individual decision tailored to each par-
ticular situation. In other words, to use the “art” of medi-
cine as well as its science. To this effect, many factors 
need to be considered.  Obviously, the younger the patient 
is, the more years that the individual would be at risk of 
developing a recurrence and the more inclined one would 
be to recommend some sort of follow-up. Conversely, 
what is there to be gained by recommending a periodic 
repeat imaging study in the future to a 71-year-old patient 
who has recovered satisfactorily from his/her SAH? Yes, 
there is a small chance that a recurrence or a new aneu-
rysm may be detected in the future, but then, particularly 
when considering that the patient would be older at that 
time, one has to factor in the risk of treating that recur-
rence, which may well be a more difficult problem to treat 
in an older patient. 
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Presence of multiple aneurysms is clearly, as dis-
cussed before, an important risk factor for recurrent SAH 
or development of a de novo aneurysm even if all the an-
eurysms are treated, and periodic imaging follow-up is 
desirable in these patients. Family history of aneurysms 
is important and one would obviously be more likely to 
recommend more careful follow-up in patients with a 
significant family history of aneurysms, since it is clear 
that in those cases the chances of developing a de novo 
aneurysm are greater. The same goes, of course, for pa-
tients with diseases that predispose them to the formation 
and/or rupture of aneurysms, such as polycystic kidney 
disease, some of the collagen vascular diseases, and so 
on. Not to be neglected, of course, is the psychological 
makeup of the patient and his/her family. All of us should 
be able to evaluate this after dealing with them through 
the patient’s illness and convalescence. We should be able 
to tell who would be relatively unaffected by the idea of 
needing follow-up just in case of the remote chance of a 
recurrence and, alternatively, who could be devastated by 
our emphasizing that such a chance exists. 
Of course it is extremely important not only what 
specific advice to give in terms of follow-up, but how that 
advice is given. For example, if we believe that the risk of 
a recurrence justifies routine imaging in, say, 2 years after 
satisfactory treatment of a ruptured aneurysm, the impact 
may be very different if we say “You know, the chances 
of your having this problem ever again are extraordinarily 
small, but I think that just to be conservative and to re-
assure you, we should get another study in 2 years,” as 
opposed to “You know, once you’ve had an SAH, you re-
ally need to be followed up very carefully because the 
aneurysm, even though we clipped it satisfactorily, could 
recur, and certainly you have a much greater risk than 
someone who has never had an aneurysm of developing 
another one, so we must do an angiogram no longer than 
2 years from now.”
In conclusion, my opinion is that the available data 
indicate that the frequency of a recurrent SAH, regrowth 
of the clipped aneurysm, or formation of a de novo aneu-
rysm in a patient who has had a ruptured aneurysm sat-
isfactorily clipped is extremely small, and therefore the 
neurosurgeon is justified in being very reassuring to such 
a patient and his/her family and is under no imperative 
to recommend routine follow-up or imaging studies to 
all these patients. Whether to do so or not should be an 
individualized decision based on a number of factors, of 
which one of the most important is the possible psycho-
logical impact on the patient and the family. Of course, 
patients in whom the aneurysm was incompletely clipped 
or coiled, patients with multiple aneurysms, a family his-
tory of aneurysms, or a disease predisposing to the for-
mation and rupture of aneurysms should have periodic 
follow-up, but the frequency of such and the way in which 
the patient is counseled, once again, requires individual 
consideration of a multiplicity of factors including psy-
chological ones. 
We are grateful to Dr. Covey and her colleagues for 
emphasizing the impact of fear of recurrence in patients 
with SAH and in their spouse or closest relative or friend.
(http://thejns.org/doi/abs/10.3171/2013.2.JNS13252)
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In his editorial on our article published in this issue 
of the Journal of Neurosurgery, Dr. Heros comments on 
the role of the neurosurgeon in promoting or mitigating 
the fear of recurrent SAH in patients and their SOs. He 
supports the widely held notion that the risk of a recur-
rent SAH from a satisfactorily clipped aneurysm is very 
small, and raises the question about how the treating neu-
rosurgeon should counsel the patient and his/her SO.
Drawing on his own personal experience, he high-
lights the limitations of simply reassuring patients that 
they had an extremely small chance of a recurrent SAH 
and that they did not need any further follow-up. The 
limitations of reassurance seemed particularly notable in 
patients who had been visiting the aneurysm clinics for 
checkups for several years since their aneurysm had been 
treated. The idea of needing a follow-up and checkup 
may in itself propagate the perception that there must be 
a noteworthy chance of recurrence, and Dr. Heros con-
cludes his editorial by presenting the opinion that recom-
mending routine follow-ups or imaging studies to all pa-
tients could be ill-advised. The approach to reassurance 
adopted, including the decision whether to offer routine 
follow-up, should be individually tailored and based on 
a number of factors, including the neurosurgeon’s evalu-
ation of the psychological make-up of the patient and the 
family.
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We think that the recommendations provided by Dr. 
Heros have the potential to reduce the problem signifi-
cantly. That being said, we would like to draw the read-
ers’ attention to the fact that counseling and information 
provided by the neurosurgeon, while being an important 
factor, is not the only relevant factor that determines the 
fears of patients and their SOs.
One potentially important factor for neurosurgeons 
to consider and identify is posttraumatic stress disorder 
(PTSD), which we have found is strongly associated with 
whether patients experience the debilitating and dispro-
portionate fear of SAH recurrence that Dr. Heros de-
scribes.7 Studies have shown that the prevalence of PTSD, 
which is characterized by intrusive recollections of the 
trauma and active avoidance of stimuli associated with 
it, can be at least 3 times times more prevalent in patients 
with SAH8 and their SOs9 than it is in the general popula-
tion. Our own research has also found that the develop-
ment of PTSD in patients with SAH appears to be related 
to the stress of postictal events, including realizing all of 
a sudden that they could have died.1 
It could therefore be argued that in PTSD the focus 
on the near miss of averting death has evoked a stress-
inducing fear response that inflates perceptions of re-
currence (“It could so easily have gone the other way—
I might not be so lucky next time”) rather than a relief 
response (“I’m thankful I’m still alive”).10 Of course, as 
shown in our article published in this issue of the Jour-
nal of Neurosurgery, the patients and their SOs may not 
share the same fears, and the reason for this may lie in 
the way that they have interpreted the future implications 
of the near-death incident. In light of the finding that SOs 
were more fearful of SAH recurrence than the patients, it 
is possible that SOs may be even more inclined than the 
patients themselves to interpret the near miss as a signal 
that their loved one “almost died” and “might not be so 
lucky next time.”
Understanding and identifying how patients with 
SAH and their SOs have interpreted the near miss might 
therefore provide neurosurgeons and other health profes-
sionals with some valuable insights into the psychologi-
cal impact that the traumatic event has had on them, and 
help target those individuals who may need more than 
standard reassurance or advice. In line with this, we pre-
viously reported how SAH patients with PTSD who were 
fearful of SAH were significantly less likely to see value 
in being provided with information about the true risk, 
in being reassured by their neurosurgeon, or in having 
repeated angiograms.7 Why was that? We suggest that 
this is because a proportion of their fear is attributable to 
abnormal risk perceptions that result from PTSD—it does 
not, as treatment with information would suggest, merely 
represent a lack of understanding or need for reassur-
ance. This argument is also supported by past research, 
which suggests that in patients who suffer from PTSD, 
information and advice alone are insufficient to alleviate 
their fears—as illustrated by the following quote from a 
qualitative study on patients with SAH conducted by Jar-
vis:4 “I felt very very [sic] frightened about it happening 
again … even though I knew the facts about the chance 
of recurrence.” 
Unfortunately, many affected SAH patients do not 
seem to recover spontaneously from PTSD without psy-
chological treatment. In a prospective study we found that 
the PTSD rates in patients with SAH were comparable 
at 3 and 13 months postictus, with most patients having 
the same PTSD status.8 Specific psychological treatments 
such as cognitive-behavioral therapy and eye-movement 
desensitization and reprocessing have, however, been 
found to be successful for PTSDs that develop after the 
experience of other traumas such as motor vehicle acci-
dents and assault.3,5,6 However, although such psychologi-
cal treatment is available and proven to be effective, its 
potential for reducing PTSD and its accompanying fears 
in patients with SAH and their SOs has not yet been eval-
uated. Whether fear in patients with SAH will be reduced 
if PTSD is effectively treated is unknown, and in our 
view such an evaluation should be an important research 
priority.
Identifying patients and their SOs who are at risk of 
PTSD and are demonstrating an abnormal fear response 
is also important. As a starting point we might therefore 
want to know whether neurosurgeons and other health 
professionals are able to identify the signs and symptoms 
in the course of their dealings with the patient and fam-
ily through their treatment and convalescence. To this 
end we have, with the help of the support groups Behind 
the Gray (www.behindthegray.net), The Brain & Spine 
Foundation (www.brainandspine.org.uk), and Headway 
(www.headway.org.uk), recently finished collecting data 
from an online survey of approximately 400 patients with 
SAH in the United Kingdom to document how well PTSD 
is being picked up within clinical practice and to what de-
gree patients are being supported for this difficulty. The 
findings have not yet been analyzed, but if we find that a 
significant number of cases are not being picked up then 
this research could lead to recommendations for routine 
use of specific screening measures for PTSD in clinical 
practice.2
If successful, the development of therapeutic ap-
proaches to reduce the PTSD in patients with SAH and 
their SOs, together with early identification, and the kind 
of tailored counseling described in Dr. Heros’ editorial 
could then ensure that patients with SAH and their SOs 
will reap the full benefit of the impressive improvements 
in the management of SAH that have been achieved in re-
cent years as consequences of scientific and technological 
advances in neurosurgery and neuroradiology. 
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